Leap Therapeutics, Inc.
(NASDAQ GM: LPTX)
Rigrodsky Law, P.A. is investigating Leap Therapeutics, Inc. (“Leap”) regarding possible breaches of fiduciary duties and other violations of law related to Leap’s agreement to be acquired by Flame Biosciences, Inc.